Metraipolis › archive › dc_949ea3296bd3

Computational drug repurposing reveals Alectinib as a potential lead targeting Cathepsin S for therapeutic developments against cancer and chronic pain — Europe PMC PMID:41069928

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41069928
DOI: 10.3389/fbinf.2025.1666573
License (as archived): solo-consultazione
Archived: 2026-11-09T18:58:26.427Z
SHA-256 of the archived text: 7e457388de744545145c6a1654ed2e8158dec5749b992cd1226fe1dcd310afe3
Stable URL of this page: https://metraipolis.com/documento/dc_949ea3296bd3

How to cite

Computational drug repurposing reveals Alectinib as a potential lead targeting Cathepsin S for therapeutic developments against cancer and chronic pain — Europe PMC PMID:41069928 — Europe PMC (en), https://europepmc.org/article/MED/41069928 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_949ea3296bd3 (Metraipolis archive dc_949ea3296bd3, sha256 7e457388de744545145c6a1654ed2e8158dec5749b992cd1226fe1dcd310afe3)

BibTeX

@misc{dc949ea3296bd3,
  title = {Computational drug repurposing reveals Alectinib as a potential lead targeting Cathepsin S for therapeutic developments against cancer and chronic pain — Europe PMC PMID:41069928},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41069928},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_949ea3296bd3; sha256 7e457388de744545145c6a1654ed2e8158dec5749b992cd1226fe1dcd310afe3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41069928. Agents can read the archived copy with the MCP tool read_document.